The global Treatments for Alpha-1 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Treatments for Alpha-1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Treatments for Alpha-1.

Report Scope

The Treatments for Alpha-1 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Treatments for Alpha-1 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Treatments for Alpha-1 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Treatments for Alpha-1 Market Report

Report Metric	Details
Report Name	Treatments for Alpha-1 Market
CAGR	5%
Segment by Type	Augmentation Therapy Cystic Fibrosis(CF) Non-CF Bronchiectasis(NCFB) Diabetes Other
Segment by Application	Hospitals Specialty Clinics Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceutical Industries, Takeda, Baxter, Grifols, CSL Behring, Kamada Ltd, Chiesi Pharmaceuticals, Kedrion Group, Vertex Pharmaceuticals, ProMetic Life Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Treatments for Alpha-1 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Treatments for Alpha-1 Market report?

Ans: The main players in the Treatments for Alpha-1 Market are Pfizer, GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceutical Industries, Takeda, Baxter, Grifols, CSL Behring, Kamada Ltd, Chiesi Pharmaceuticals, Kedrion Group, Vertex Pharmaceuticals, ProMetic Life Sciences

What are the Application segmentation covered in the Treatments for Alpha-1 Market report?

Ans: The Applications covered in the Treatments for Alpha-1 Market report are Hospitals, Specialty Clinics, Pharmacies

What are the Type segmentation covered in the Treatments for Alpha-1 Market report?

Ans: The Types covered in the Treatments for Alpha-1 Market report are Augmentation Therapy, Cystic Fibrosis(CF), Non-CF Bronchiectasis(NCFB), Diabetes, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Treatments for Alpha-1 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Augmentation Therapy

1.2.3 Cystic Fibrosis(CF)

1.2.4 Non-CF Bronchiectasis(NCFB)

1.2.5 Diabetes

1.2.6 Other

1.3 Market by Application

1.3.1 Global Treatments for Alpha-1 Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Treatments for Alpha-1 Market Perspective (2019-2030)

2.2 Treatments for Alpha-1 Growth Trends by Region

2.2.1 Global Treatments for Alpha-1 Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Treatments for Alpha-1 Historic Market Size by Region (2019-2024)

2.2.3 Treatments for Alpha-1 Forecasted Market Size by Region (2025-2030)

2.3 Treatments for Alpha-1 Market Dynamics

2.3.1 Treatments for Alpha-1 Industry Trends

2.3.2 Treatments for Alpha-1 Market Drivers

2.3.3 Treatments for Alpha-1 Market Challenges

2.3.4 Treatments for Alpha-1 Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Treatments for Alpha-1 Players by Revenue

3.1.1 Global Top Treatments for Alpha-1 Players by Revenue (2019-2024)

3.1.2 Global Treatments for Alpha-1 Revenue Market Share by Players (2019-2024)

3.2 Global Treatments for Alpha-1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Treatments for Alpha-1 Revenue

3.4 Global Treatments for Alpha-1 Market Concentration Ratio

3.4.1 Global Treatments for Alpha-1 Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Treatments for Alpha-1 Revenue in 2023

3.5 Treatments for Alpha-1 Key Players Head office and Area Served

3.6 Key Players Treatments for Alpha-1 Product Solution and Service

3.7 Date of Enter into Treatments for Alpha-1 Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Treatments for Alpha-1 Breakdown Data by Type

4.1 Global Treatments for Alpha-1 Historic Market Size by Type (2019-2024)

4.2 Global Treatments for Alpha-1 Forecasted Market Size by Type (2025-2030)

5 Treatments for Alpha-1 Breakdown Data by Application

5.1 Global Treatments for Alpha-1 Historic Market Size by Application (2019-2024)

5.2 Global Treatments for Alpha-1 Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Treatments for Alpha-1 Market Size (2019-2030)

6.2 North America Treatments for Alpha-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Treatments for Alpha-1 Market Size by Country (2019-2024)

6.4 North America Treatments for Alpha-1 Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Treatments for Alpha-1 Market Size (2019-2030)

7.2 Europe Treatments for Alpha-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Treatments for Alpha-1 Market Size by Country (2019-2024)

7.4 Europe Treatments for Alpha-1 Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Treatments for Alpha-1 Market Size (2019-2030)

8.2 Asia-Pacific Treatments for Alpha-1 Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Treatments for Alpha-1 Market Size by Region (2019-2024)

8.4 Asia-Pacific Treatments for Alpha-1 Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Treatments for Alpha-1 Market Size (2019-2030)

9.2 Latin America Treatments for Alpha-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Treatments for Alpha-1 Market Size by Country (2019-2024)

9.4 Latin America Treatments for Alpha-1 Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Treatments for Alpha-1 Market Size (2019-2030)

10.2 Middle East & Africa Treatments for Alpha-1 Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Treatments for Alpha-1 Market Size by Country (2019-2024)

10.4 Middle East & Africa Treatments for Alpha-1 Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Treatments for Alpha-1 Introduction

11.1.4 Pfizer Revenue in Treatments for Alpha-1 Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 GlaxoSmithKline

11.2.1 GlaxoSmithKline Company Detail

11.2.2 GlaxoSmithKline Business Overview

11.2.3 GlaxoSmithKline Treatments for Alpha-1 Introduction

11.2.4 GlaxoSmithKline Revenue in Treatments for Alpha-1 Business (2019-2024)

11.2.5 GlaxoSmithKline Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Detail

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Treatments for Alpha-1 Introduction

11.3.4 AstraZeneca Revenue in Treatments for Alpha-1 Business (2019-2024)

11.3.5 AstraZeneca Recent Development

11.4 Boehringer Ingelheim

11.4.1 Boehringer Ingelheim Company Detail

11.4.2 Boehringer Ingelheim Business Overview

11.4.3 Boehringer Ingelheim Treatments for Alpha-1 Introduction

11.4.4 Boehringer Ingelheim Revenue in Treatments for Alpha-1 Business (2019-2024)

11.4.5 Boehringer Ingelheim Recent Development

11.5 Teva Pharmaceutical Industries

11.5.1 Teva Pharmaceutical Industries Company Detail

11.5.2 Teva Pharmaceutical Industries Business Overview

11.5.3 Teva Pharmaceutical Industries Treatments for Alpha-1 Introduction

11.5.4 Teva Pharmaceutical Industries Revenue in Treatments for Alpha-1 Business (2019-2024)

11.5.5 Teva Pharmaceutical Industries Recent Development

11.6 Takeda

11.6.1 Takeda Company Detail

11.6.2 Takeda Business Overview

11.6.3 Takeda Treatments for Alpha-1 Introduction

11.6.4 Takeda Revenue in Treatments for Alpha-1 Business (2019-2024)

11.6.5 Takeda Recent Development

11.7 Baxter

11.7.1 Baxter Company Detail

11.7.2 Baxter Business Overview

11.7.3 Baxter Treatments for Alpha-1 Introduction

11.7.4 Baxter Revenue in Treatments for Alpha-1 Business (2019-2024)

11.7.5 Baxter Recent Development

11.8 Grifols

11.8.1 Grifols Company Detail

11.8.2 Grifols Business Overview

11.8.3 Grifols Treatments for Alpha-1 Introduction

11.8.4 Grifols Revenue in Treatments for Alpha-1 Business (2019-2024)

11.8.5 Grifols Recent Development

11.9 CSL Behring

11.9.1 CSL Behring Company Detail

11.9.2 CSL Behring Business Overview

11.9.3 CSL Behring Treatments for Alpha-1 Introduction

11.9.4 CSL Behring Revenue in Treatments for Alpha-1 Business (2019-2024)

11.9.5 CSL Behring Recent Development

11.10 Kamada Ltd

11.10.1 Kamada Ltd Company Detail

11.10.2 Kamada Ltd Business Overview

11.10.3 Kamada Ltd Treatments for Alpha-1 Introduction

11.10.4 Kamada Ltd Revenue in Treatments for Alpha-1 Business (2019-2024)

11.10.5 Kamada Ltd Recent Development

11.11 Chiesi Pharmaceuticals

11.11.1 Chiesi Pharmaceuticals Company Detail

11.11.2 Chiesi Pharmaceuticals Business Overview

11.11.3 Chiesi Pharmaceuticals Treatments for Alpha-1 Introduction

11.11.4 Chiesi Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2019-2024)

11.11.5 Chiesi Pharmaceuticals Recent Development

11.12 Kedrion Group

11.12.1 Kedrion Group Company Detail

11.12.2 Kedrion Group Business Overview

11.12.3 Kedrion Group Treatments for Alpha-1 Introduction

11.12.4 Kedrion Group Revenue in Treatments for Alpha-1 Business (2019-2024)

11.12.5 Kedrion Group Recent Development

11.13 Vertex Pharmaceuticals

11.13.1 Vertex Pharmaceuticals Company Detail

11.13.2 Vertex Pharmaceuticals Business Overview

11.13.3 Vertex Pharmaceuticals Treatments for Alpha-1 Introduction

11.13.4 Vertex Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2019-2024)

11.13.5 Vertex Pharmaceuticals Recent Development

11.14 ProMetic Life Sciences

11.14.1 ProMetic Life Sciences Company Detail

11.14.2 ProMetic Life Sciences Business Overview

11.14.3 ProMetic Life Sciences Treatments for Alpha-1 Introduction

11.14.4 ProMetic Life Sciences Revenue in Treatments for Alpha-1 Business (2019-2024)

11.14.5 ProMetic Life Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Boehringer Ingelheim

Teva Pharmaceutical Industries

Chiesi Pharmaceuticals

Kedrion Group

Vertex Pharmaceuticals

ProMetic Life Sciences

List of Tables

Table 1. Global Treatments for Alpha-1 Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Augmentation Therapy

Table 3. Key Players of Cystic Fibrosis(CF)

Table 4. Key Players of Non-CF Bronchiectasis(NCFB)

Table 5. Key Players of Diabetes

Table 6. Key Players of Other

Table 7. Global Treatments for Alpha-1 Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Treatments for Alpha-1 Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Treatments for Alpha-1 Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Treatments for Alpha-1 Market Share by Region (2019-2024)

Table 11. Global Treatments for Alpha-1 Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Treatments for Alpha-1 Market Share by Region (2025-2030)

Table 13. Treatments for Alpha-1 Market Trends

Table 14. Treatments for Alpha-1 Market Drivers

Table 15. Treatments for Alpha-1 Market Challenges

Table 16. Treatments for Alpha-1 Market Restraints

Table 17. Global Treatments for Alpha-1 Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Treatments for Alpha-1 Market Share by Players (2019-2024)

Table 19. Global Top Treatments for Alpha-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatments for Alpha-1 as of 2023)

Table 20. Ranking of Global Top Treatments for Alpha-1 Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Treatments for Alpha-1 Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Treatments for Alpha-1 Product Solution and Service

Table 24. Date of Enter into Treatments for Alpha-1 Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Treatments for Alpha-1 Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Treatments for Alpha-1 Revenue Market Share by Type (2019-2024)

Table 28. Global Treatments for Alpha-1 Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Treatments for Alpha-1 Revenue Market Share by Type (2025-2030)

Table 30. Global Treatments for Alpha-1 Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Treatments for Alpha-1 Revenue Market Share by Application (2019-2024)

Table 32. Global Treatments for Alpha-1 Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Treatments for Alpha-1 Revenue Market Share by Application (2025-2030)

Table 34. North America Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Treatments for Alpha-1 Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Treatments for Alpha-1 Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Treatments for Alpha-1 Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Treatments for Alpha-1 Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Treatments for Alpha-1 Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Treatments for Alpha-1 Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Treatments for Alpha-1 Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Treatments for Alpha-1 Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Treatments for Alpha-1 Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Treatments for Alpha-1 Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Treatments for Alpha-1 Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Treatments for Alpha-1 Market Size by Country (2025-2030) & (US$ Million)

Table 49. Pfizer Company Detail

Table 50. Pfizer Business Overview

Table 51. Pfizer Treatments for Alpha-1 Product

Table 52. Pfizer Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. GlaxoSmithKline Company Detail

Table 55. GlaxoSmithKline Business Overview

Table 56. GlaxoSmithKline Treatments for Alpha-1 Product

Table 57. GlaxoSmithKline Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 58. GlaxoSmithKline Recent Development

Table 59. AstraZeneca Company Detail

Table 60. AstraZeneca Business Overview

Table 61. AstraZeneca Treatments for Alpha-1 Product

Table 62. AstraZeneca Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 63. AstraZeneca Recent Development

Table 64. Boehringer Ingelheim Company Detail

Table 65. Boehringer Ingelheim Business Overview

Table 66. Boehringer Ingelheim Treatments for Alpha-1 Product

Table 67. Boehringer Ingelheim Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 68. Boehringer Ingelheim Recent Development

Table 69. Teva Pharmaceutical Industries Company Detail

Table 70. Teva Pharmaceutical Industries Business Overview

Table 71. Teva Pharmaceutical Industries Treatments for Alpha-1 Product

Table 72. Teva Pharmaceutical Industries Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 73. Teva Pharmaceutical Industries Recent Development

Table 74. Takeda Company Detail

Table 75. Takeda Business Overview

Table 76. Takeda Treatments for Alpha-1 Product

Table 77. Takeda Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 78. Takeda Recent Development

Table 79. Baxter Company Detail

Table 80. Baxter Business Overview

Table 81. Baxter Treatments for Alpha-1 Product

Table 82. Baxter Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 83. Baxter Recent Development

Table 84. Grifols Company Detail

Table 85. Grifols Business Overview

Table 86. Grifols Treatments for Alpha-1 Product

Table 87. Grifols Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 88. Grifols Recent Development

Table 89. CSL Behring Company Detail

Table 90. CSL Behring Business Overview

Table 91. CSL Behring Treatments for Alpha-1 Product

Table 92. CSL Behring Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 93. CSL Behring Recent Development

Table 94. Kamada Ltd Company Detail

Table 95. Kamada Ltd Business Overview

Table 96. Kamada Ltd Treatments for Alpha-1 Product

Table 97. Kamada Ltd Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 98. Kamada Ltd Recent Development

Table 99. Chiesi Pharmaceuticals Company Detail

Table 100. Chiesi Pharmaceuticals Business Overview

Table 101. Chiesi Pharmaceuticals Treatments for Alpha-1 Product

Table 102. Chiesi Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 103. Chiesi Pharmaceuticals Recent Development

Table 104. Kedrion Group Company Detail

Table 105. Kedrion Group Business Overview

Table 106. Kedrion Group Treatments for Alpha-1 Product

Table 107. Kedrion Group Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 108. Kedrion Group Recent Development

Table 109. Vertex Pharmaceuticals Company Detail

Table 110. Vertex Pharmaceuticals Business Overview

Table 111. Vertex Pharmaceuticals Treatments for Alpha-1 Product

Table 112. Vertex Pharmaceuticals Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 113. Vertex Pharmaceuticals Recent Development

Table 114. ProMetic Life Sciences Company Detail

Table 115. ProMetic Life Sciences Business Overview

Table 116. ProMetic Life Sciences Treatments for Alpha-1 Product

Table 117. ProMetic Life Sciences Revenue in Treatments for Alpha-1 Business (2019-2024) & (US$ Million)

Table 118. ProMetic Life Sciences Recent Development

Table 119. Research Programs/Design for This Report

Table 120. Key Data Information from Secondary Sources

Table 121. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Treatments for Alpha-1 Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Treatments for Alpha-1 Market Share by Type: 2023 VS 2030

Figure 3. Augmentation Therapy Features

Figure 4. Cystic Fibrosis(CF) Features

Figure 5. Non-CF Bronchiectasis(NCFB) Features

Figure 6. Diabetes Features

Figure 7. Other Features

Figure 8. Global Treatments for Alpha-1 Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Treatments for Alpha-1 Market Share by Application: 2023 VS 2030

Figure 10. Hospitals Case Studies

Figure 11. Specialty Clinics Case Studies

Figure 12. Pharmacies Case Studies

Figure 13. Treatments for Alpha-1 Report Years Considered

Figure 14. Global Treatments for Alpha-1 Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Treatments for Alpha-1 Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Treatments for Alpha-1 Market Share by Region: 2023 VS 2030

Figure 17. Global Treatments for Alpha-1 Market Share by Players in 2023

Figure 18. Global Top Treatments for Alpha-1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Treatments for Alpha-1 as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Treatments for Alpha-1 Revenue in 2023

Figure 20. North America Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Treatments for Alpha-1 Market Share by Country (2019-2030)

Figure 22. United States Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Treatments for Alpha-1 Market Share by Country (2019-2030)

Figure 26. Germany Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Treatments for Alpha-1 Market Share by Region (2019-2030)

Figure 34. China Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Treatments for Alpha-1 Market Share by Country (2019-2030)

Figure 42. Mexico Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Treatments for Alpha-1 Market Share by Country (2019-2030)

Figure 46. Turkey Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Treatments for Alpha-1 Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 49. GlaxoSmithKline Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 50. AstraZeneca Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 51. Boehringer Ingelheim Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 52. Teva Pharmaceutical Industries Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 53. Takeda Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 54. Baxter Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 55. Grifols Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 56. CSL Behring Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 57. Kamada Ltd Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 58. Chiesi Pharmaceuticals Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 59. Kedrion Group Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 60. Vertex Pharmaceuticals Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 61. ProMetic Life Sciences Revenue Growth Rate in Treatments for Alpha-1 Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Stainless Steel Medication Trolley Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-18N15820

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Instant Molecular Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33G15638

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Universal Cell Therapy Drug Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14U15769

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

Global Preclinical Toxicology Testing Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-1P15930

Wed Aug 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions